2016 Medical Technology Showcase

2016 Medical Technology Showcase2016-02-05T13:32:52+00:00

The Coalition for Imaging and Bioengineering Research is proud to host the 7th Annual Medical Technology Showcase: 

Collaborating to Enhance Patient Care Through Advances in Biomedical Imaging

[twocol_one]

Picture2

April in Washington D.C.

[/twocol_one] [twocol_one_last]

The 7th Annual Showcase recognizes how imaging technology impacts patient care from detection to diagnosis and treatment

The event will be held, Tuesday, April 12 from 5:00pm – 7:00pm in the  Kennedy Caucus Room, 325 Russell Senate Office Bldg.

Join us to learn from patients, academic researchers, and industry manufacturers how imaging technology impacts patient care from detection to diagnosis and treatment.  Refreshments available.

Attendance to this event is free.  Registration is now available online.

Register

 

 

For questions and more information, please contact  [email protected]. Visit the 2015 Medical Technology Showcase page for highlights and more information from last year’s event.

[/twocol_one_last]
[hr]7th Annual Medical Technology Showcase Updates:

February 4, 2016: The Academy of Radiology Research Academic Council Announces Travel Award Recipients for the 2016 Medical Technology Showcase

The Academy is proud to announce the 2016 recipients of stipends from the Academy of Radiology Research Academic Council (ARRAC) to travel to Washington DC and participate in the 7th Annual Coalition for Imaging and Bioengineering Research (CIBR) Medical Technology Showcase on Capitol Hill.

[hr]

This widely-attended event is sponsored by a 501(c)(6) organization
CIBR is a permanent partnership of academic research departments, scientific societies, patient advocacy organizations, and imaging equipment manufacturers leading the education and advocacy efforts for imaging research. CIBR facilitates consistent open dialog among all stakeholders of the imaging community, and provides a conduit for disseminating information between academia, industry, patient groups, and public policy makers.